ArticleBioorganic & medicinal chemistry2026
Experimental and computational analysis of SERCA inhibition by naphthoquinone derivatives.
Article in Bioorganic & medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Naphthoquinones are small aromatic compounds with diverse biological activities and established applications in medicine and industry. Previous studies have identified a limited number of naphthoquinones that inhibit the sarco/endoplasmic reticulum calcium ATPase (SERCA), an ion-translocating enzyme that plays a central role in cellular calcium homeostasis. To further explore naphthoquinone-mediated SERCA inhibition and its molecular determinants, we evaluated the inhibitory potencies of 13 commercially available naphthoquinones using enzyme activity assays with SERCA1a, enabling the establishment of structure-activity relationships (SARs). The most potent compounds inhibited SERCA at low micromolar concentrations and were characterized by the presence of a hydroxy or nitro substituent at the C5 position. In contrast, electronegative substituents at the C2 position produced mixed effects on potency whereas increased steric bulk reduced or eliminated inhibitory potency. Possible inhibition mechanisms were considered, including covalent modification of cysteine residues and reversible binding to defined sites on the enzyme, with the latter being more consistent with the observed SARs. Molecular simulations of naphthoquinone binding to SERCA further supported this model and provided insight into potential ligand-protein interactions within the ATP-binding pocket.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.